BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 303104)

  • 1. Depressed in vitro B-lymphocyte differentiation in systemic lupus erythematosus.
    Bobrove AM; Miller P
    Arthritis Rheum; 1977; 20(7):1326-33. PubMed ID: 303104
    [No Abstract]   [Full Text] [Related]  

  • 2. Diminished response to an inhibitory signal in lymphocytes from patients with systemic lupus erythematosus.
    Salata M; Golbus J; Richardson BC
    Clin Exp Immunol; 1988 Mar; 71(3):439-44. PubMed ID: 3260156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity in systemic lupus erythematosus: observations on in vitro cell-mediated immune responses in relationship to number of potentially reactive T cells, disease activity, and treatment.
    Bell DA
    Clin Immunol Immunopathol; 1978 Mar; 9(3):301-17. PubMed ID: 304790
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic lupus erythematosus and common variable panhypogammaglobulinemia: a patient with absence of circulating B cells.
    Goldstein R; Izaguirre C; Smith CD; Mierins E; Karsh J
    Arthritis Rheum; 1985 Jan; 28(1):100-3. PubMed ID: 3871328
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired immunoglobulin M synthesis by peripheral blood lymphocytes in systemic lupus erythematosus: a primary B-cell defect.
    Nies KM; Stevens RH; Louie JS
    Clin Immunol Immunopathol; 1981 Apr; 19(1):118-30. PubMed ID: 6452238
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneously enhanced in vitro immunoglobulin synthesis by B cells in systemic lupus erythematosus.
    Okudaira K; Tanimoto K; Nakamura T; Horiuchi Y
    Clin Immunol Immunopathol; 1980 Jul; 16(3):267-78. PubMed ID: 6967383
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of circulating T and B lymphocytes in discoid versus systemic lupus erythematosus.
    Gilliam JN; Hurd ER
    Clin Immunol Immunopathol; 1976 Sep; 6(2):149-55. PubMed ID: 1085683
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cellular interaction in the pokeweed-mitogen induced terminal differentiation to polyclonal immunoglobulin production in human B lymphocytes in vitro].
    Robert M; Abuaf N; Valet JP; Daguilland F
    Ann Immunol (Paris); 1977; 128(1-2):47-9. PubMed ID: 300608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [No correlation between suppressor cell function and disease activity in natural history studies of patients with systemic lupus erythematosus].
    Rautenstrauch H; Frank F; Saal JG
    Z Rheumatol; 1985; 44(3):133-6. PubMed ID: 2932868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antilymphocyte antibody in systemic lupus erythematosus on in vitro Ig synthesis.
    Okudaira K; Tanimoto K; Horiuchi Y
    Clin Immunol Immunopathol; 1981 Nov; 21(2):162-71. PubMed ID: 6457712
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte surface immunoglobulins in autoimmune diseases.
    Gergely P; Szegedi G; Fekete B; Szabó G; Petrányi G
    Lancet; 1973 Mar; 1(7801):482-3. PubMed ID: 4120390
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of IgM- and IgG-secreting B cells in the peripheral blood of patients with systemic lupus erythematosus.
    Klinman DM; Shirai A; Ishigatsubo Y; Conover J; Steinberg AD
    Arthritis Rheum; 1991 Nov; 34(11):1404-10. PubMed ID: 1719987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panhypogammaglobulinemia in systemic lupus erythematosus: in vitro demonstration of multiple cellular defects.
    Ashman RF; White RH; Wiesenhutter C; Cantor Y; Lasarow E; Liebling M; Talal N
    J Allergy Clin Immunol; 1982 Dec; 70(6):465-73. PubMed ID: 6216277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective depletion of Ig-bearing lymphocytes by cyclophosphamide in rheumatoid arthritis and systemic lupus erythematosus. Guidelines for dosage.
    Horwitz DA
    Arthritis Rheum; 1974; 17(4):363-74. PubMed ID: 4605097
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lymphocyte population in systemic lupus erythematosus].
    Del Pozo Pérez MA; Prieto Valtueña J; González Guilabert MI; Velasco Alonso R
    Rev Clin Esp; 1975 Mar; 136(6):527-30. PubMed ID: 1079620
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological reaction to nuclear antigens in children with systemic lupus erythematosus].
    Levina SG; Ausharipova ShR
    Pediatriia; 1981 Sep; (9):35-7. PubMed ID: 6975464
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormalities of immune regulation in the connective tissue diseases.
    Jasin HE
    Semin Arthritis Rheum; 1983 Aug; 13(1 Suppl 1):94-8. PubMed ID: 6353583
    [No Abstract]   [Full Text] [Related]  

  • 18. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up of immunological parameters and therapy of systemic lupus erythematosus].
    Kreuzfelder E; Rodeck U; Brittinger G; Kirch W; Scheiermann N
    Immun Infekt; 1986 Apr; 14(2):73-5. PubMed ID: 3519434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of cord blood lymphocytes into IgA-producing cells in response to breast milk stimulatory factor.
    Pittard WB; Bill K
    Clin Immunol Immunopathol; 1979 Aug; 13(4):430-4. PubMed ID: 314877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.